Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

Now, it’s worth noting Stock Advisor's total average return is 1,028% — a market-crushing outperformance compared to 190% for ...

If you are eyeing Vertex and wondering whether now is the right moment to jump in, you are not alone. The company has certainly grabbed attention lately. In just the last week, the stock moved up 2.4% ...

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the best long term low volatility stocks to buy right now. Bank ...

Warren Buffett famously said that he and his investing managers "attempt to be fearful when others are greedy, and to be greedy only when others are fearful." With the stock marke ...

Vertex Pharmaceuticals has a lot of buy and hold ratings, but there aren't any sell ratings from Wall Street analysts. Around 75,000 people with cystic fibrosis rely on Vertex Pharmaceuticals to keep ...

Vertex Pharmaceuticals Incorporated VRTX stock has declined 23.6% in the past six months, mainly due to recent pipeline setbacks. In August 2025, Vertex’s phase II study on the oral formulation of ...

Conestoga Capital Advisors, an asset management company, released its third-quarter 2025 investor letter. A copy of the ...

Vertex Pharmaceuticals (NASDAQ: VRTX) has outperformed the market over the past 10 years by 1.56% on an annualized basis producing an average annual return of 14.01%. Currently, Vertex Pharmaceuticals ...

Vertex (VERX) closed the last trading session at $25.86, gaining 3.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street ...